_id
691b21f93c536f8df2318e04
Ticker
XLS.SW
Name
Xlife Sciences AG
Exchange
SW
Address
Talacker 35, Zurich, Switzerland, 8001
Country
Switzerland
Sector
Healthcare
Industry
Biotechnology
Currency
CHF
Website
https://www.xlifesciences.ch
Description
Xlife Sciences AG focuses on the development and commercialization of research projects in the life sciences sector. The company's project covers technology platforms, biotechnology/therapies, medical technology, and artificial intelligence/digital health areas that focuses on identifying new therapeutic approaches and biomarkers for common diseases based on human genetic data. It also produces, researches, develops, and manufactures the chemical and active pharmaceutical ingredients for human and veterinary medicines; and offers clinical research organization services. In addition, the company builds a bridge between research/ development and healthcare markets, as well as support researchers and entrepreneurs in the positioning, structuring, development, and implementation of their ideas; and operates as an active ingredient manufacturer. Further, it focuses on identifying innovative biomarkers in the field of kidney diseases; the development of antibody-drug conjugates through a click chemistry approach and microfluidic screening of functional antibodies; and provides Neuromex, a screening instrument for the early-stage detection of neurological diseases. Xlife Sciences AG was founded in 2019 and is headquartered in Zurich, Switzerland.
Last Close
25.5
Volume
7106
Current Price
24.7
Change
0.1
Last Updated
2026-01-01T00:16:29.377Z
Image
https://logo.clearbit.com/www.xlifesciences.ch
Ipo Date
-
Market Cap
142459040
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
354320
Cost Of Revenue
168310
Gross Profit
186010
Operating Expenses
9785080
Operating Income
-9430760
Interest Expense
-
Pretax Income
-8203580
Net Income
-3050490
Eps
-0.5312804239807586
Dividends Per Share
-
Shares Outstanding
5767572
Income Tax Expense
-
EBITDA
-
Operating Margin
-2661.650485436893
Total Other Income Expense Net
-
Cash
51553
Short Term Investments
-
Receivables
9415900
Inventories
45700
Total Current Assets
13115070
Property Plant Equipment
210806
Total Assets
536257320
Payables
920554
Short Term Debt
0
Long Term Debt
53922200
Total Liabilities
232837680
Equity
303419640
Bs_currency_symbol
CHF
Depreciation
7996420
Change In Working Capital
-761480
Cash From Operations
-803620
Capital Expenditures
0
Cash From Investing
-1773550
Cash From Financing
2529700
Net Change In Cash
-47480
Cf_currency_symbol
-
PE
6.0539
PB
0.46741113726191225
ROE
-1.00536998857424
ROA
-0.5688481790794017
FCF
-803620
Fcf Percent
-2.2680627681192145
Piotroski FScore
1
Health Score
30
Deep Value Investing Score
7
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
5.8
Garp Investing Score
2
Growth Investing Score
1.5
Momentum Investing Score
7.5
Net Net Investing Score
1
Quality Investing Score
2.5
Value Investing Score
7.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
354320
Quarters > 0 > income Statement > cost Of Revenue
168310
Quarters > 0 > income Statement > gross Profit
186010
Quarters > 0 > income Statement > operating Expenses
9785080
Quarters > 0 > income Statement > operating Income
-9430760
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-8203580
Quarters > 0 > income Statement > net Income
-3050490
Quarters > 0 > income Statement > eps
-0.5312804239807586
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
5741770
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-2661.650485436893
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
51553
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
9415900
Quarters > 0 > balance Sheet > inventories
45700
Quarters > 0 > balance Sheet > total Current Assets
13115070
Quarters > 0 > balance Sheet > property Plant Equipment
210806
Quarters > 0 > balance Sheet > total Assets
536257320
Quarters > 0 > balance Sheet > payables
920554
Quarters > 0 > balance Sheet > short Term Debt
0
Quarters > 0 > balance Sheet > long Term Debt
53922200
Quarters > 0 > balance Sheet > total Liabilities
232837680
Quarters > 0 > balance Sheet > equity
303419640
Quarters > 0 > balance Sheet > currency_symbol
CHF
Quarters > 0 > cash Flow > net Income
-5833930
Quarters > 0 > cash Flow > depreciation
7996420
Quarters > 0 > cash Flow > change In Working Capital
-761480
Quarters > 0 > cash Flow > cash From Operations
-803620
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-1773550
Quarters > 0 > cash Flow > cash From Financing
2529700
Quarters > 0 > cash Flow > net Change In Cash
-47480
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.5312804239807586
Quarters > 0 > ratios > PB
0.46741113726191225
Quarters > 0 > ratios > ROE
-1.00536998857424
Quarters > 0 > ratios > ROA
-0.5688481790794017
Quarters > 0 > ratios > FCF
-803620
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-2.2680627681192145
Quarters > 0 > health Score
30
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
485060
Quarters > 1 > income Statement > cost Of Revenue
149210
Quarters > 1 > income Statement > gross Profit
335850
Quarters > 1 > income Statement > operating Expenses
10511260
Quarters > 1 > income Statement > operating Income
-10026200
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
28552360
Quarters > 1 > income Statement > net Income
33803610
Quarters > 1 > income Statement > eps
5.887315235545834
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
5741770
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-2067.0020203686145
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
CHF
Quarters > 1 > balance Sheet > cash
99028
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
8464060
Quarters > 1 > balance Sheet > inventories
45360
Quarters > 1 > balance Sheet > total Current Assets
14209700
Quarters > 1 > balance Sheet > property Plant Equipment
269191
Quarters > 1 > balance Sheet > total Assets
540372130
Quarters > 1 > balance Sheet > payables
1026081
Quarters > 1 > balance Sheet > short Term Debt
0
Quarters > 1 > balance Sheet > long Term Debt
53890370
Quarters > 1 > balance Sheet > total Liabilities
235112020
Quarters > 1 > balance Sheet > equity
305260120
Quarters > 1 > balance Sheet > currency_symbol
CHF
Quarters > 1 > cash Flow > net Income
28706540
Quarters > 1 > cash Flow > depreciation
16061680
Quarters > 1 > cash Flow > change In Working Capital
-3117030
Quarters > 1 > cash Flow > cash From Operations
-421510
Quarters > 1 > cash Flow > capital Expenditures
12090
Quarters > 1 > cash Flow > cash From Investing
-3998500
Quarters > 1 > cash Flow > cash From Financing
4298030
Quarters > 1 > cash Flow > net Change In Cash
-119680
Quarters > 1 > cash Flow > currency_symbol
CHF
Quarters > 1 > ratios > PE
5.887315235545834
Quarters > 1 > ratios > PB
0.46459301332909125
Quarters > 1 > ratios > ROE
11.073706581783432
Quarters > 1 > ratios > ROA
6.255616846856999
Quarters > 1 > ratios > FCF
-433600
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-0.8939100317486497
Quarters > 1 > health Score
59
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
349820
Quarters > 2 > income Statement > cost Of Revenue
136150
Quarters > 2 > income Statement > gross Profit
213670
Quarters > 2 > income Statement > operating Expenses
9670010
Quarters > 2 > income Statement > operating Income
-9320190
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-4585130
Quarters > 2 > income Statement > net Income
473230
Quarters > 2 > income Statement > eps
0.08297491447918658
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
5703290
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-2664.281630552856
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
CHF
Quarters > 2 > balance Sheet > cash
99776
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
9092850
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
17949430
Quarters > 2 > balance Sheet > property Plant Equipment
376620
Quarters > 2 > balance Sheet > total Assets
509861530
Quarters > 2 > balance Sheet > payables
825838
Quarters > 2 > balance Sheet > short Term Debt
0
Quarters > 2 > balance Sheet > long Term Debt
53046590
Quarters > 2 > balance Sheet > total Liabilities
237036900
Quarters > 2 > balance Sheet > equity
272824630
Quarters > 2 > balance Sheet > currency_symbol
CHF
Quarters > 2 > cash Flow > net Income
-2236080
Quarters > 2 > cash Flow > depreciation
7956130
Quarters > 2 > cash Flow > change In Working Capital
-585920
Quarters > 2 > cash Flow > cash From Operations
-997950
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-344330
Quarters > 2 > cash Flow > cash From Financing
1223350
Quarters > 2 > cash Flow > net Change In Cash
-118930
Quarters > 2 > cash Flow > currency_symbol
CHF
Quarters > 2 > ratios > PE
0.08297491447918658
Quarters > 2 > ratios > PB
0.5163436417012642
Quarters > 2 > ratios > ROE
0.17345574701228406
Quarters > 2 > ratios > ROA
0.0928153963685003
Quarters > 2 > ratios > FCF
-997950
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-2.852752844319936
Quarters > 2 > health Score
44
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
640460
Quarters > 3 > income Statement > cost Of Revenue
314790
Quarters > 3 > income Statement > gross Profit
325670
Quarters > 3 > income Statement > operating Expenses
-
Quarters > 3 > income Statement > operating Income
-9345310
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
15509770
Quarters > 3 > income Statement > net Income
20763160
Quarters > 3 > income Statement > eps
3.7128188988768467
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
5592290
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-1459.1559191830872
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
CHF
Quarters > 3 > balance Sheet > cash
218706
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
9127170
Quarters > 3 > balance Sheet > inventories
0
Quarters > 3 > balance Sheet > total Current Assets
18118490
Quarters > 3 > balance Sheet > property Plant Equipment
393673
Quarters > 3 > balance Sheet > total Assets
511993590
Quarters > 3 > balance Sheet > payables
971899
Quarters > 3 > balance Sheet > short Term Debt
0
Quarters > 3 > balance Sheet > long Term Debt
55572550
Quarters > 3 > balance Sheet > total Liabilities
243820320
Quarters > 3 > balance Sheet > equity
268173270
Quarters > 3 > balance Sheet > currency_symbol
CHF
Quarters > 3 > cash Flow > net Income
10381581
Quarters > 3 > cash Flow > depreciation
16030410
Quarters > 3 > cash Flow > change In Working Capital
-4721250
Quarters > 3 > cash Flow > cash From Operations
171780
Quarters > 3 > cash Flow > capital Expenditures
41080
Quarters > 3 > cash Flow > cash From Investing
-1014100
Quarters > 3 > cash Flow > cash From Financing
828550
Quarters > 3 > cash Flow > net Change In Cash
-2330
Quarters > 3 > cash Flow > currency_symbol
CHF
Quarters > 3 > ratios > PE
3.7128188988768467
Quarters > 3 > ratios > PB
0.515075805280668
Quarters > 3 > ratios > ROE
7.742442041296658
Quarters > 3 > ratios > ROA
4.0553554586493945
Quarters > 3 > ratios > FCF
130700
Quarters > 3 > ratios > Piotroski FScore
3
Quarters > 3 > ratios > fcf Percent
0.20407207319738938
Quarters > 3 > health Score
73
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
834880
Annuals > 0 > income Statement > cost Of Revenue
285350
Annuals > 0 > income Statement > gross Profit
549530
Annuals > 0 > income Statement > operating Expenses
20181270
Annuals > 0 > income Statement > operating Income
-19346390
Annuals > 0 > income Statement > interest Expense
473173
Annuals > 0 > income Statement > pretax Income
23967230
Annuals > 0 > income Statement > net Income
34276840
Annuals > 0 > income Statement > eps
5.969734071549365
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
5741770
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-2317.265954388655
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
CHF
Annuals > 0 > balance Sheet > cash
99028
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
8464060
Annuals > 0 > balance Sheet > inventories
45360
Annuals > 0 > balance Sheet > total Current Assets
14209700
Annuals > 0 > balance Sheet > property Plant Equipment
269191
Annuals > 0 > balance Sheet > total Assets
540372130
Annuals > 0 > balance Sheet > payables
1026081
Annuals > 0 > balance Sheet > short Term Debt
0
Annuals > 0 > balance Sheet > long Term Debt
53890370
Annuals > 0 > balance Sheet > total Liabilities
235112020
Annuals > 0 > balance Sheet > equity
305260120
Annuals > 0 > balance Sheet > currency_symbol
CHF
Annuals > 0 > cash Flow > net Income
28706540
Annuals > 0 > cash Flow > depreciation
16061680
Annuals > 0 > cash Flow > change In Working Capital
-3117030
Annuals > 0 > cash Flow > cash From Operations
-421510
Annuals > 0 > cash Flow > capital Expenditures
12090
Annuals > 0 > cash Flow > cash From Investing
-3998500
Annuals > 0 > cash Flow > cash From Financing
4298030
Annuals > 0 > cash Flow > net Change In Cash
-119680
Annuals > 0 > cash Flow > currency_symbol
CHF
Annuals > 0 > ratios > PE
5.969734071549365
Annuals > 0 > ratios > PB
0.46459301332909125
Annuals > 0 > ratios > ROE
11.228731745240747
Annuals > 0 > ratios > ROA
6.343191681628732
Annuals > 0 > ratios > FCF
-433600
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
-0.5193560751245688
Annuals > 0 > health Score
59
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
988440
Annuals > 1 > income Statement > cost Of Revenue
539420
Annuals > 1 > income Statement > gross Profit
449020
Annuals > 1 > income Statement > operating Expenses
21296370
Annuals > 1 > income Statement > operating Income
-20307930
Annuals > 1 > income Statement > interest Expense
385031
Annuals > 1 > income Statement > pretax Income
4533920
Annuals > 1 > income Statement > net Income
14879300
Annuals > 1 > income Statement > eps
2.6606810447956026
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
5592290
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-2054.5435231273523
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
CHF
Annuals > 1 > balance Sheet > cash
218706
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
9127173
Annuals > 1 > balance Sheet > inventories
0
Annuals > 1 > balance Sheet > total Current Assets
18118490
Annuals > 1 > balance Sheet > property Plant Equipment
393673
Annuals > 1 > balance Sheet > total Assets
511993590
Annuals > 1 > balance Sheet > payables
971899
Annuals > 1 > balance Sheet > short Term Debt
0
Annuals > 1 > balance Sheet > long Term Debt
55572550
Annuals > 1 > balance Sheet > total Liabilities
243820320
Annuals > 1 > balance Sheet > equity
268173270
Annuals > 1 > balance Sheet > currency_symbol
CHF
Annuals > 1 > cash Flow > net Income
9273230
Annuals > 1 > cash Flow > depreciation
16030410
Annuals > 1 > cash Flow > change In Working Capital
-4721250
Annuals > 1 > cash Flow > cash From Operations
171780
Annuals > 1 > cash Flow > capital Expenditures
41080
Annuals > 1 > cash Flow > cash From Investing
-1014100
Annuals > 1 > cash Flow > cash From Financing
828550
Annuals > 1 > cash Flow > net Change In Cash
-2330
Annuals > 1 > cash Flow > currency_symbol
CHF
Annuals > 1 > ratios > PE
2.6606810447956026
Annuals > 1 > ratios > PB
0.515075805280668
Annuals > 1 > ratios > ROE
5.548390411915401
Annuals > 1 > ratios > ROA
2.9061496648815464
Annuals > 1 > ratios > FCF
130700
Annuals > 1 > ratios > Piotroski FScore
4
Annuals > 1 > ratios > fcf Percent
0.13222856217878678
Annuals > 1 > health Score
65
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
1027970
Annuals > 2 > income Statement > cost Of Revenue
842330
Annuals > 2 > income Statement > gross Profit
185640
Annuals > 2 > income Statement > operating Expenses
22010890
Annuals > 2 > income Statement > operating Income
-20982920
Annuals > 2 > income Statement > interest Expense
687473
Annuals > 2 > income Statement > pretax Income
4038990
Annuals > 2 > income Statement > net Income
14312030
Annuals > 2 > income Statement > eps
2.7087033377998835
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
5283720
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-2041.1996459040633
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
CHF
Annuals > 2 > balance Sheet > cash
221035
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
545211
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
1245430
Annuals > 2 > balance Sheet > property Plant Equipment
535579
Annuals > 2 > balance Sheet > total Assets
490230350
Annuals > 2 > balance Sheet > payables
627002
Annuals > 2 > balance Sheet > short Term Debt
0
Annuals > 2 > balance Sheet > long Term Debt
60236830
Annuals > 2 > balance Sheet > total Liabilities
254996320
Annuals > 2 > balance Sheet > equity
235234040
Annuals > 2 > balance Sheet > currency_symbol
CHF
Annuals > 2 > cash Flow > net Income
14312030
Annuals > 2 > cash Flow > depreciation
16022320
Annuals > 2 > cash Flow > change In Working Capital
-490050
Annuals > 2 > cash Flow > cash From Operations
-4607480
Annuals > 2 > cash Flow > capital Expenditures
80160
Annuals > 2 > cash Flow > cash From Investing
-1684910
Annuals > 2 > cash Flow > cash From Financing
4556300
Annuals > 2 > cash Flow > net Change In Cash
-1735320
Annuals > 2 > cash Flow > currency_symbol
CHF
Annuals > 2 > ratios > PE
2.7087033377998835
Annuals > 2 > ratios > PB
0.5548001641259063
Annuals > 2 > ratios > ROE
6.084166220160993
Annuals > 2 > ratios > ROA
2.919450009572031
Annuals > 2 > ratios > FCF
-4687640
Annuals > 2 > ratios > Piotroski FScore
2
Annuals > 2 > ratios > fcf Percent
-4.560094166172164
Annuals > 2 > health Score
46
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
806070
Annuals > 3 > income Statement > cost Of Revenue
446950
Annuals > 3 > income Statement > gross Profit
359120
Annuals > 3 > income Statement > operating Expenses
6039088
Annuals > 3 > income Statement > operating Income
-5233020
Annuals > 3 > income Statement > interest Expense
495179
Annuals > 3 > income Statement > pretax Income
53194820
Annuals > 3 > income Statement > net Income
53418480
Annuals > 3 > income Statement > eps
10.558535124632606
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
5059270
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-649.2016822360341
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
CHF
Annuals > 3 > balance Sheet > cash
1956351
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
483660
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
2472370
Annuals > 3 > balance Sheet > property Plant Equipment
669567
Annuals > 3 > balance Sheet > total Assets
480064390
Annuals > 3 > balance Sheet > payables
378307
Annuals > 3 > balance Sheet > short Term Debt
0
Annuals > 3 > balance Sheet > long Term Debt
62970820
Annuals > 3 > balance Sheet > total Liabilities
268829680
Annuals > 3 > balance Sheet > equity
211234710
Annuals > 3 > balance Sheet > currency_symbol
CHF
Annuals > 3 > cash Flow > net Income
53418480
Annuals > 3 > cash Flow > depreciation
66682
Annuals > 3 > cash Flow > change In Working Capital
-8518800
Annuals > 3 > cash Flow > cash From Operations
-4324080
Annuals > 3 > cash Flow > capital Expenditures
1212040
Annuals > 3 > cash Flow > cash From Investing
-7033340
Annuals > 3 > cash Flow > cash From Financing
8595330
Annuals > 3 > cash Flow > net Change In Cash
-2746450
Annuals > 3 > cash Flow > currency_symbol
CHF
Annuals > 3 > ratios > PE
10.558535124632606
Annuals > 3 > ratios > PB
0.5915882337708609
Annuals > 3 > ratios > ROE
25.288684799955462
Annuals > 3 > ratios > ROA
11.127357311380667
Annuals > 3 > ratios > FCF
-5536120
Annuals > 3 > ratios > Piotroski FScore
2
Annuals > 3 > ratios > fcf Percent
-6.868038755939311
Annuals > 3 > health Score
60
Valuation > metrics > PE
6.0539
Valuation > metrics > PB
0.46741113726191225
Valuation > final Score
90
Valuation > verdict
46.4% Undervalued
Profitability > metrics > ROE
-1.00536998857424
Profitability > metrics > ROA
-23.259425988576503
Profitability > metrics > Net Margin
-8.609420862497178
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.7673784070141274
Risk > final Score
68
Risk > verdict
High
Liquidity > metrics > Current Ratio
14.246931738931123
Liquidity > metrics > Quick Ratio
14.19728772022065
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
90
Prev Valuations > 1
90
Prev Valuations > 2
90
Prev Profitabilities > 0
82
Prev Profitabilities > 1
38
Prev Profitabilities > 2
75
Prev Risks > 0
68
Prev Risks > 1
68
Prev Risks > 2
68
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:11:44.307Z
Earnings History > 0 > period
2025-06-30
Earnings History > 0 > report Date
2025-09-23
Earnings History > 0 > date
2025-06-30
Earnings History > 0 > before After Market
BeforeMarket
Earnings History > 0 > currency
CHF
Earnings History > 0 > eps Actual
-0.53
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-03-31
Earnings History > 1 > report Date
2025-04-25
Earnings History > 1 > date
2025-03-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
4.46
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
4.46
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-06-30
Earnings History > 2 > report Date
2024-09-18
Earnings History > 2 > date
2024-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.08
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
0.08
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2023-03-31
Earnings History > 3 > report Date
2023-04-20
Earnings History > 3 > date
2023-03-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
CHF
Earnings History > 3 > eps Actual
2.36
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2022-06-30
Earnings History > 4 > report Date
2022-09-28
Earnings History > 4 > date
2022-06-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
CHF
Earnings History > 4 > eps Actual
-1.48
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-1.48
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2022-03-31
Earnings History > 5 > report Date
2022-06-30
Earnings History > 5 > date
2022-03-31
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
CHF
Earnings History > 5 > eps Actual
7.07
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
7.07
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2021-06-30
Earnings History > 6 > report Date
2021-08-10
Earnings History > 6 > date
2021-06-30
Earnings History > 6 > before After Market
AfterMarket
Earnings History > 6 > currency
CHF
Earnings History > 6 > eps Actual
0.88
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
0.88
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2021-03-31
Earnings History > 7 > report Date
2021-04-26
Earnings History > 7 > date
2021-03-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
CHF
Earnings History > 7 > eps Actual
2.42
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
2.42
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2020-09-30
Earnings History > 8 > report Date
2020-12-29
Earnings History > 8 > date
2020-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
CHF
Earnings History > 8 > eps Actual
-0.04
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.04
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2020-03-31
Earnings History > 9 > report Date
2020-06-10
Earnings History > 9 > date
2020-03-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
CHF
Earnings History > 9 > eps Actual
0.3
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
0.3
Earnings History > 9 > surprise Percent
-
Xlife Sciences AG focuses on the development and commercialization of research projects in the life sciences sector. The company's project covers technology platforms, biotechnology/therapies, medical technology, and artificial intelligence/digital health areas that focuses on identifying new therapeutic approaches and biomarkers for common diseases based on human genetic data. It also produces, researches, develops, and manufactures the chemical and active pharmaceutical ingredients for human and veterinary medicines; and offers clinical research organization services. In addition, the company builds a bridge between research/ development and healthcare markets, as well as support researchers and entrepreneurs in the positioning, structuring, development, and implementation of their ideas; and operates as an active ingredient manufacturer. Further, it focuses on identifying innovative biomarkers in the field of kidney diseases; the development of antibody-drug conjugates through a click chemistry approach and microfluidic screening of functional antibodies; and provides Neuromex, a screening instrument for the early-stage detection of neurological diseases. Xlife Sciences AG was founded in 2019 and is headquartered in Zurich, Switzerland.
Stock Price
CHF0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AWith 50% ownership, Xlife Sciences AG (VTX:XLS) insiders have a lot at stake - Yahoo Finance
12/30/2025
With 50% ownership, Xlife Sciences AG (VTX:XLS) insiders have a lot at stake Yahoo Finance
Read more →(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
Very High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Xlife Sciences AG
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-06-30
EPS Actual
-0.53
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
CHF 0
Cost Of Revenue
CHF 0
Gross Profit
CHF 0
Operating Expenses
CHF 0
Operating Income
CHF 0
Interest Expense
CHF 0
Pretax Income
CHF 0
Net Income
CHF 0
Income Tax Expense
CHF 0
EBITDA
CHF 0
Total Other Income Expense Net
CHF 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
CHF 0
Short Term Investments
CHF 0
Receivables
CHF 0
Inventories
CHF 0
Total Current Assets
CHF 0
Property Plant Equipment
CHF 0
Total Assets
CHF 0
Payables
CHF 0
Short Term Debt
CHF 0
Long Term Debt
CHF 0
Total Liabilities
CHF 0
Equity
CHF 0
(Last Updated 2025-06-30)
Net Income
CHF 0
Depreciation
CHF 0
Change In Working Capital
CHF 0
Cash From Operations
CHF 0
Capital Expenditures
CHF 0
Cash From Investing
CHF 0
Cash From Financing
CHF 0
Net Change In Cash
CHF 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.